Company: XERI
Filing Date: 2025-11-19
Form Type: 10-Q
Source: 0001477932-25-008494
Chunk: 44

Company: XERIANT, INC.
Filing Date: 2025-11-19
Form: 10-Q
Item: Part I, Item 1
Chunk 44
---
ANT, INC.

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ DEFICIT

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2024

UNAUDITED

  Series A Preferred Stock  Series B Preferred Stock  Common Stock  Common stock to be  Additional Paid in  Accumulated  Non-Controlling     Shares  Amount  Shares  Amount  Shares  Amount  issued  Capital  Deficit  Interest  Total Balance June 30, 2024  705,895  $7   1,000,000  $10   524,853,304  $5,248  $51,950  $20,899,187  $(26,708,915 ) $(2,859,941 ) $(8,612,454)                                             Stock issued for services  -   -   -   -   11,902,182   119   -   217,393   -   -   217,512                                              Conversion of Series A Preferred to Common Stock  (6,479 )  -   -   -   6,479,000   65   -   (65 )  -   -   -                                              Conversion of convertible notes payable and accrued interest into common stock  -   -   -   -   26,950,000   270   -   269,231   -   -   269,501                                              Net loss  -   -   -   -   -   -   -   -   (364,846 )  (7,376 )  (372,222 )                                             Balance September 30, 2024  699,416  $7   1,000,000  $10   570,184,486  $5,702  $51,950  $21,385,746  $(27,073,761 ) $(2,867,317 ) $(8,497,663 )